Crossmark

The effect of selenium supplementation on disease activity and immune-inflammatory biomarkers in patients with mild-to-moderate ulcerative colitis: a randomized, double-blind, placebo-controlled clinical trial

Crossref DOI link: https://doi.org/10.1007/s00394-023-03214-9

Published Online: 2023-07-31

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khazdouz, Maryam

Daryani, Naser Ebrahimi

Cheraghpour, Makan https://orcid.org/0000-0003-4459-4528
Alborzi, Foroogh

Hasani, Motahareh

Ghavami, Shaghayegh Baradaran

Shidfar, Farzad
Clinical Trials ^BETA

Clinical trials referenced in this document:

irct20091114002709n51 at Iranian Registry of Clinical Trials

Documents that mention this clinical trial

The effect of selenium supplementation on disease activity and immune-inflammatory biomarkers in patients with mild-to-moderate ulcerative colitis: a randomized, double-blind, placebo-controlled clinical trial
https://doi.org/10.1007/s00394-023-03214-9
Funding

Funding for this research was provided by:

Iran University of Medical Sciences
License Information

Text and Data Mining valid from 2023-07-31

Version of Record valid from 2023-07-31
More Information

Article History

Received: 13 October 2022

Accepted: 14 July 2023

First Online: 31 July 2023

Declarations

:

: The authors declare that they have no conflicts of interest.

Document is current

Any future updates will be listed below